← Eichor
Study identifier: NCT06601140 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode

Condition: Major Depressive Disorder (MDD)  ·  Sponsor: Emobot

PhaseNA
Planned participants104
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this clinical investigation is to find out whether the EMOCARE emotional monitoring software provides consistent results compared with the tools available for assessing the emotional state of patients suffering from mild to moderately severe depressive episod. It will also provide information on how patients feel about the use of passive monitoring software (without the active involvement of patient). The main questions it aims to answer are as follows: Does EMOCARE provide consistent results compared with tools already used in current practice? What are the medical problems encountered by participants when using EMOCARE? The researchers will compare EMCOCARE to various questionnaires usually used in the management of patients suffering from depression (PHQ-9, MADRS, GAD-7, BDI-II, EQ-5D-5L). Participants who agree to take part in the study, during a selection visit, will be able to: 1. Install the software on a digital interface (smartphone, computer, etc.) and activate or deactivate it whenever they wish during the 6-week follow-up period. 2. Attend 2 scheduled appointments at the centre (a first appointment then a second 6 weeks later) to complete a series of questionnaires, being questioned by the doctor, and fill in other questionnaires on their own. 3. At home, answer questionnaires independently, 2 weeks and 4 weeks after the first appointment. 4. Receive a telephone call from the doctor 3 weeks after the first appointment to find out how the participant…

This description comes directly from the study's public registry record.

Talk to the study team

Tanel PETELOT  ·  +33 6 51 44 26 67  ·  tanel.petelot@emobot.fr

Always discuss trial participation with your own doctor first.

Locations (11)

Private psychiatric practiceAgen, FranceRecruiting
Private psychiatric praticeCaen, FranceRecruiting
Centre Psychothérapique de NancyLaxou, FranceNot Yet Recruiting
Private psychiatric practiceMaxéville, FranceTerminated
Private psychiatric practiceNantes, FranceRecruiting
Centre Hospitalier Universitaire de NantesNantes, FranceNot Yet Recruiting
Private psychiatric practiceParis, FranceNot Yet Recruiting
Private psychiatric practiceReims, FranceNot Yet Recruiting
Centre hospitalier Guillaume RégnierRennes, FranceRecruiting
Private psychiatric practiceSaint-Grégoire, FranceRecruiting
Private psychiatric practiceSaint-Nazaire, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06601140